For most people with thyroid eye disease, a thyroidectomy helps stabilize the condition but does not fully reverse eye changes on its own. Removing the thyroid lowers the antibodies driving the disease, and some patients do see modest improvement, but the eye changes often persist to some degree because the autoimmune process in the eye tissue operates partly independently of the thyroid gland itself.
How much your eyes improve depends on several factors: how severe the disease was before surgery, how long it’s been active, whether you smoke, and what additional treatments you pursue afterward. Here’s what the evidence actually shows.
Why Thyroidectomy Alone Isn’t a Cure for Eye Changes
Thyroid eye disease is caused by antibodies that attack tissues behind and around your eyes, causing swelling, bulging, and eyelid changes. These same antibodies target the thyroid, which is why the two conditions travel together. Removing the thyroid does reduce antibody levels over time. A meta-analysis of multiple studies confirmed that antibody levels decline after total thyroidectomy, and more patients see their antibody levels normalize compared to other treatments.
But lower antibodies don’t automatically translate to better eyes. That same body of research found no significant difference in eye disease improvement after thyroidectomy compared to other approaches for managing Graves’ disease. The reason: by the time many patients have surgery, the inflammation has already remodeled the fat and muscle tissue around the eyes. Once that structural change happens, it tends to stay even after the immune trigger quiets down.
In one long-term study of surgical patients, eye disease didn’t change at all in about 78% of cases. It improved in roughly 17% and worsened in about 6%. Those numbers are actually better than radioactive iodine treatment, where only 3% improved and over 10% got worse. So surgery does carry a relative advantage, but “no change” is still the most common outcome for the eyes themselves.
What Tends to Improve and What Doesn’t
Thyroid eye disease goes through two phases. The active phase involves inflammation, redness, swelling, and pain, and lasts an average of about 2.7 years. Once that quiets down, you enter the inactive or chronic phase. Redness, swelling, and discomfort typically improve as the active phase ends, whether or not you’ve had a thyroidectomy.
What often doesn’t resolve on its own is the structural damage left behind: bulging eyes (proptosis), restricted eye movement, double vision, and changes in eyelid position. Studies of chronic thyroid eye disease patients in the U.S. found that appearance and visual function remain affected long after the inflammation has settled. Patients reported ongoing impairment in vision, appearance, and psychosocial well-being years into the chronic phase, with an average total disease duration of nearly six years.
Eyelid Retraction
The wide-eyed “stare” caused by upper eyelid retraction is one of the most noticeable cosmetic changes. Research published in the British Journal of Ophthalmology tracked this specific symptom over time in patients who received no surgical correction for it. The eyelid position gradually improved, with about 22% of eyes normalizing by six months, 37% by one year, and just under 50% by two years. The average time to normalization was between 12 and 18 months. So there’s a reasonable chance of improvement here, but roughly half of patients still had abnormal lid position at the two-year mark. A family history of thyroid eye disease was associated with a 6.2 times lower likelihood of the lids returning to normal.
How Smoking Affects Your Recovery
If you smoke, your chances of your eyes improving are significantly lower. Smoking is one of the strongest and most consistent risk factors for both developing and worsening thyroid eye disease. In a study comparing treatment outcomes, smokers saw far less reduction in eye bulging than non-smokers. Non-smokers averaged about 4 mm of proptosis reduction per eye, while smokers averaged only 1.2 to 1.75 mm. Smokers were also more likely to have double vision before treatment and showed less overall improvement in disease activity. Quitting smoking is one of the most impactful things you can do to give your eyes the best chance of recovery.
Treatments That Can Help After Surgery
If your eyes don’t return to normal after thyroidectomy and the disease stabilizes, there are effective treatments available. The approach generally follows a specific sequence: medical therapy first, then orbital decompression if needed, followed by eye muscle surgery, and finally eyelid surgery.
Teprotumumab (Tepezza)
This is the first medication specifically approved for thyroid eye disease, and it targets the receptor that the disease-causing antibodies bind to behind the eyes. In clinical trials, 83% of treated patients achieved a reduction in eye bulging of 2 mm or more after a 24-week course, compared to just 10% on placebo. The average reduction was about 3.3 mm. For patients who relapse after a first course, about 60% respond to a second round. However, some regression does occur over time. Research from Harvard found that about two-thirds of eyes experienced some return of bulging after treatment, typically within the first year, though most patients still maintained improvement compared to where they started.
Orbital Decompression Surgery
For bulging eyes that persist after the active phase ends, orbital decompression surgery removes bone or fat from the eye socket to allow the eyes to settle back. This is typically performed at least six months after the active inflammatory phase resolves. It’s also done urgently in cases where the optic nerve is being compressed and vision is threatened. Decompression is performed before any eye muscle or eyelid surgery, since repositioning the eye can change how the muscles and lids function.
Eyelid and Muscle Surgery
Double vision caused by scarred or thickened eye muscles can be corrected with strabismus surgery once the disease is stable. Eyelid retraction that hasn’t normalized on its own can be addressed with eyelid repositioning surgery. These are typically the last steps in a staged rehabilitation process and are done after any decompression work is complete.
A Realistic Timeline
The active inflammatory phase of thyroid eye disease lasts an average of 2.7 years, though it varies widely. Most doctors will want to see at least six months of stable, inactive disease before recommending corrective surgery. So a realistic timeline from thyroidectomy to final cosmetic and functional outcome, if corrective procedures are needed, can stretch to several years.
During that waiting period, some natural improvement does happen. Eyelid position tends to improve most in the 12 to 18 month window. Swelling and redness settle as inflammation fades. But if you still have significant proptosis, double vision, or lid retraction after the disease stabilizes, those changes are unlikely to resolve further without intervention. The good news is that the available treatments, particularly teprotumumab and staged surgical rehabilitation, can produce meaningful improvement for the majority of patients. Your eyes may not look exactly as they did before Graves’ disease, but for many people, the combination of thyroidectomy and targeted follow-up care gets them much closer to where they want to be.